Ischemic Stroke News and Research

RSS

11th World Stroke Congress examines high stroke impact in low- and middle-income countries

11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care, recovery and rehabilitation in 100s of sessions and oral posters.

22 Oct 2018

Incidence of stroke has risen steadily among marijuana users, show studies

11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care, rehabilitation and recovery in 100s of sessions and oral posters.

19 Oct 2018

Molecule research reveals potential drug target for treating stroke patients

In an extension of research published a month ago in Nature Methods, a novel hybrid approach performed by researchers from Clemson University's department of physics and astronomy and Stony Brook University has revealed a 3-D structure of a protein fragment that could serve as a drug target in treating stroke patients.

3 Oct 2018

UCalgary study could help physicians make better treatment decisions for stroke

More than 80 percent of strokes are caused when a blood vessel to the brain becomes blocked, called an ischemic stroke.

19 Sep 2018

Daily low-dose aspirin does not prolong healthy life in older people, study finds

In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia or persistent physical disability).

17 Sep 2018

Administering tPA depending on location of clot can be as effective as thrombectomy

There are two main treatments for stroke caused by a clot in a blood vessel in the brain. One treatment, mechanical thrombectomy, involves pulling the clot out with a specialized catheter that is inserted into the artery in the groin and guided by imaging to the clot.

12 Sep 2018

New guidelines outline criteria for stroke centers offering ischemic stroke interventions to patients

The Society of NeuroInterventional Surgery today joined 12 other neurointerventional societies to release new guidelines outlining the criteria for Level 1, 2 and 3 stroke centers that provide acute ischemic stroke interventions to stroke patients.

7 Sep 2018

Penumbra introduces new advancements in stroke thrombectomy aspiration technology

Penumbra, Inc., a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System's most advanced technology: Penumbra JET 7 and Penumbra JET D Reperfusion Catheters powered by the Penumbra ENGINE aspiration source.

4 Sep 2018

Amphetamine regimen does not improve post-stroke motor recovery

A pilot clinical trial exploring the benefit of d-amphetamine combined with physical therapy for stroke patients found no evidence that the regimen improved post-stroke motor recovery.

27 Aug 2018

CERENOVUS wins European CE mark approval for BRAVO Flow Diverter to treat intracranial aneurysms

CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced today it has received European CE mark approval for its BRAVO Flow Diverter. The device is approved for use in the treatment of patients suffering from intracranial aneurysms.

22 Aug 2018

Stroke patients appear to receive better care at teaching hospitals with less chance of readmission

Stroke patients appear to receive better care at teaching hospitals with less of a chance of landing back in a hospital during the early stages of recovery, according to new research from The University of Texas Health Science Center at Houston.

17 Aug 2018

Rethinking fundamental rule of stroke care: 'Time is brain!'

In 1993, neurologist Camilo R. Gomez, MD, coined a phrase that for a quarter century has been a fundamental rule of stroke care: "Time is brain!"

14 Aug 2018

CERENOVUS announces launch of novel stent retriever for treating stroke patients

CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next-generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.

26 Jul 2018

Dizziness could be an early sign of dementia finds study

A new study has found that people who feel dizzy when they stand up from lying down or sitting positions, are more at risk of developing dementia or stroke. The study was published in the latest issue of the journal Neurology.

25 Jul 2018

Falling temperatures may lead to rise in numbers of deaths from stroke

A study performed by Brazilian researchers and published in the International Journal of Biometeorology showed that falling temperatures may be accompanied by rising numbers of deaths from stroke, especially among people over 65.

20 Jul 2018

Certain blood thinners may increase risk of bleeding in CKD patients

Certain blood thinners approved to treat atrial fibrillation may put patients with chronic kidney disease at a higher risk of bleeding, according to the results of a study in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

13 Jul 2018

Catheter-based ablation procedure reduces risks of death, stroke in AFib patients

Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the common form of heart arrhythmia known as atrial fibrillation, or AFib, new research from UC Davis physicians shows.

30 Jun 2018

Studying The Effects of Microgravity on Muscle Mass

Studying the effects of gravity on muscle cells can give us an insight into muscle wastage diseases, and potentially guide the development of new therapies. Professor Louis Yuge discusses his research and the cellular changes that occur in response to microgravity.

25 Jun 2018

Neural Analytics wins CE Mark for NeuralBot System

Neural Analytics, Inc., a medical robotics company developing and commercializing technologies to measure and track brain health, announced today that it received CE Mark for its NeuralBot™ System, a robotic assistance technology which automatically adjusts orientation and position of its ultrasound products under the guidance of a healthcare professional.

22 Jun 2018

Massive analysis of genomes reveals insights into genetic overlap among psychiatric diseases

A massive undertaking by the Brainstorm Consortium to analyze the genomes of nearly 900,000 people has revealed important insights into the genetic overlap among some psychiatric diseases, as well as among personality traits.

21 Jun 2018